Many cellular events that lead to cancer and the progression of human disease represent aberrant gene expression and transcription. Our goal is to design molecules that can be programmed to bind with high affinity and specificity to a broad repertoire of DMA sites, permeate living human cells, traffic to the nucleus, bind DMA on chromatin and modulate transcription.
The specific aims are to invent chemically robust heterocycles for minor groove recognition, explore new chemistry for targeting DMA in a chromatin context, explore chemistry for template-mediated ligation of modular units on the nucleosome core particle, exploit (3-linked polyamides for targeting purine tracts of GAA repeats to reverse the transcription inhibition of frataxin gene expression in Friedreich's Ataxia disease, and image the kinetics and organ distribution of [F- 18] labeled polyamides in living mice by positron emission tomography (PET) scanning. The long term goals of this program are to understand how these small molecules interact with the transcriptional machinery in cells in order to externally control and reprogram gene expression. To achieve these goals, the research program combines synthetic organic chemistry (with an emphasis on heterocycles), biophysical chemistry (quantitative footprinting titration, gel mobility shift assays), cell biology (confocal microscopy, qRT-PCR/mRNA, microarray analysis of global gene expression). Although gene regulation studies in small animals are planned, our efforts are not simply aimed at medicinal chemistry. Our studies also contribute to the basic biology of gene regulation in eukaryotic cells, and the potential therapeutic value of small molecule regulation of gene expression. Much needs to be learned about chromatin and promoter accessibility before DNA-targeted therapeutics are realized and it is our goal to contribute to this basic knowledge through our studies with programmable DMA binding oligomers. The ability to control gene expression by cell permeable small molecules would have profound implications for human medicine.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM027681-28
Application #
7334200
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Preusch, Peter C
Project Start
1980-04-01
Project End
2009-11-30
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
28
Fiscal Year
2008
Total Cost
$334,046
Indirect Cost
Name
California Institute of Technology
Department
Type
Schools of Engineering
DUNS #
009584210
City
Pasadena
State
CA
Country
United States
Zip Code
91125
Kurmis, Alexis A; Yang, Fei; Welch, Timothy R et al. (2017) A Pyrrole-Imidazole Polyamide Is Active against Enzalutamide-Resistant Prostate Cancer. Cancer Res 77:2207-2212
Xu, Jun; Lahiri, Indrajit; Wang, Wei et al. (2017) Structural basis for the initiation of eukaryotic transcription-coupled DNA repair. Nature 551:653-657
Mysore, Veena S; Szablowski, Jerzy; Dervan, Peter B et al. (2016) A DNA-binding Molecule Targeting the Adaptive Hypoxic Response in Multiple Myeloma Has Potent Antitumor Activity. Mol Cancer Res 14:253-66
Xu, Liang; Wang, Wei; Gotte, Deanna et al. (2016) RNA polymerase II senses obstruction in the DNA minor groove via a conserved sensor motif. Proc Natl Acad Sci U S A 113:12426-12431
Szablowski, Jerzy O; Raskatov, Jevgenij A; Dervan, Peter B (2016) An HRE-Binding Py-Im Polyamide Impairs Hypoxic Signaling in Tumors. Mol Cancer Ther 15:608-17
Kang, JeenJoo S; Dervan, Peter B (2015) A sequence-specific DNA binding small molecule triggers the release of immunogenic signals and phagocytosis in a model of B-cell lymphoma. Q Rev Biophys 48:453-64
Hargrove, Amanda E; Martinez, Thomas F; Hare, Alissa A et al. (2015) Tumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide. PLoS One 10:e0143161
Kang, JeenJoo S; Meier, Jordan L; Dervan, Peter B (2014) Design of sequence-specific DNA binding molecules for DNA methyltransferase inhibition. J Am Chem Soc 136:3687-94
Raskatov, Jevgenij A; Szablowski, Jerzy O; Dervan, Peter B (2014) Tumor xenograft uptake of a pyrrole-imidazole (Py-Im) polyamide varies as a function of cell line grafted. J Med Chem 57:8471-6
Martínez, Thomas F; Phillips, John W; Karanja, Kenneth K et al. (2014) Replication stress by Py-Im polyamides induces a non-canonical ATR-dependent checkpoint response. Nucleic Acids Res 42:11546-59

Showing the most recent 10 out of 77 publications